Derek J. Maetzold serves as the President and Chief Executive Officer at Castle Biosciences, Inc., a company dedicated to advancing diagnostic solutions for dermatological, ophthalmic, and other diseases. With a robust background in healthcare and molecular diagnostics, Maetzold has been instrumental in steering Castle Biosciences towards its mission of improving patient care through innovative testing. Prior to joining Castle Biosciences, he held significant leadership roles that honed his expertise in the field. Notably, he was the President and CEO of Miraca Life Sciences, where he led the company to become a major player in the anatomic pathology sector. His strategic vision and operational acumen have been pivotal in driving Castle Biosciences' growth and development. Under Maetzold's leadership, Castle Biosciences has seen remarkable achievements, including the expansion of its product portfolio and the enhancement of its market presence. He has successfully guided the company through the complexities of bringing new diagnostic tests to market, ensuring they meet rigorous scientific and regulatory standards. His commitment to innovation is evident in the company's ongoing research and development efforts, which aim to address unmet needs in disease diagnosis and management. Maetzold's role at Castle Biosciences extends beyond executive oversight; he is deeply involved in fostering a culture of excellence and collaboration, which has been crucial in attracting top talent and maintaining high employee morale. His leadership continues to propel Castle Biosciences forward, solidifying its position as a leader in the molecular diagnostics industry.